Vertex Facing Uncertain Growth Path Amid AI Fears, Morgan Stanley Says

MT Newswires Live07-21

Vertex (VERX) is going through a transition period, facing an uncertain path to growth as its end market remains reluctant to adopt artificial intelligence, Morgan Stanley said in a Tuesday note.

With new Chief Executive Chris Young at the helm, the company is shaking up its leadership team and focusing on new product development, but it could still take time to improve net retention rate, the investment firm said.

"Given tax compliance requires high levels of accuracy, controls, and auditability, it will take time for these risk-averse buyers to get fully comfortable adopting and scaling new AI products," Morgan Stanley said, noting the AI opportunity in automating certain tax and compliance processes.

The brokerage said the AI journey for Vertex could take relatively longer, but the company still has secular tailwinds such as e-invoicing and tax complexity.

Morgan Stanley downgraded Vertex to equalweight from overweight and cut its price target to $15 from $19.

Price: 12.15, Change: -0.74, Percent Change: -5.74

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2653206786?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-21 23:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2653206786","market":"nz","top_or_hot":-1,"title":"Vertex Facing Uncertain Growth Path Amid AI Fears, Morgan Stanley Says","media":"MT Newswires Live","content":"<html><body><p> Vertex (VERX) is going through a transition period, facing an uncertain path to growth as its end market remains reluctant to adopt artificial intelligence, Morgan Stanley said in a Tuesday note.</p><p>With new Chief Executive Chris Young at the helm, the company is shaking up its leadership team and focusing on new product development, but it could still take time to improve net retention rate, the investment firm said.</p><p>\"Given tax compliance requires high levels of accuracy, controls, and auditability, it will take time for these risk-averse buyers to get fully comfortable adopting and scaling new AI products,\" Morgan Stanley said, noting the AI opportunity in automating certain tax and compliance processes.</p><p>The brokerage said the AI journey for Vertex could take relatively longer, but the company still has secular tailwinds such as e-invoicing and tax complexity.</p><p>Morgan Stanley downgraded Vertex to equalweight from overweight and cut its price target to $15 from $19.</p><p>Price: 12.15, Change: -0.74, Percent Change: -5.74</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vertex Facing Uncertain Growth Path Amid AI Fears, Morgan Stanley Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVertex Facing Uncertain Growth Path Amid AI Fears, Morgan Stanley Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-07-21 23:06</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Vertex (VERX) is going through a transition period, facing an uncertain path to growth as its end market remains reluctant to adopt artificial intelligence, Morgan Stanley said in a Tuesday note.</p><p>With new Chief Executive Chris Young at the helm, the company is shaking up its leadership team and focusing on new product development, but it could still take time to improve net retention rate, the investment firm said.</p><p>\"Given tax compliance requires high levels of accuracy, controls, and auditability, it will take time for these risk-averse buyers to get fully comfortable adopting and scaling new AI products,\" Morgan Stanley said, noting the AI opportunity in automating certain tax and compliance processes.</p><p>The brokerage said the AI journey for Vertex could take relatively longer, but the company still has secular tailwinds such as e-invoicing and tax complexity.</p><p>Morgan Stanley downgraded Vertex to equalweight from overweight and cut its price target to $15 from $19.</p><p>Price: 12.15, Change: -0.74, Percent Change: -5.74</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0109394709.USD","symbol_name":"富兰克林生物科技新领域基金A (acc)","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2653206786","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2653206786","pubTimestamp":1784646388,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Vertex  is going through a transition period, facing an uncertain path to growth as its end market remains reluctant to adopt artificial intelligence, Morgan Stanley said in a Tuesday note.With new Chief Executive Chris Young at the helm, the company is shaking up its leadership team and focusing on new product development, but it could still take time to improve net retention rate, the investment firm said.\"Given tax compliance requires high levels of accuracy, controls, and auditability, it will take time for these risk-averse buyers to get fully comfortable adopting and scaling new AI products,\" Morgan Stanley said, noting the AI opportunity in automating certain tax and compliance processes.The brokerage said the AI journey for Vertex could take relatively longer, but the company still has secular tailwinds such as e-invoicing and tax complexity.Morgan Stanley downgraded Vertex to equalweight from overweight and cut its price target to $15 from $19.Price: 12.15, Change: -0.74, Perc","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","BK4585":"ETF&股票定投概念","LU2417539215.USD":"ALLIANZ GLOBAL INCOME \"AMF\" (USD) INC","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","TBXU":"Direxion Daily Biotech Top 5 Bull 2X ETF","IDNA":"iShares Genomics Immunology and Healthcare ETF","BK4139":"生物科技","QTOC":"Innovator Growth Accelerated Plus ETF - October","VERX":"Vertex, Inc.","IE00B894F039.SGD":"Legg Mason ClearBridge - US Aggressive Growth A Acc SGD-H","AGIX":"通用人工智能 ETF-AGIX","LU1069344957.HKD":"AB SICAV I - AMERICAN GROWTH PORTFOLIO \"AD\" (HKD) INC","IBBQ":"Invesco Nasdaq Biotechnology ETF","LU1778281490.HKD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AD\" (HKD) INC","LU0058720904.USD":"联博国际健康护理基金A","LU2324357040.USD":"HSBC GIF GLOBAL EQUITY SUSTAINABLE HEALTHCARE \"AC\" (USD) ACC","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","LU2362541273.HKD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (HKD) ACC","LU1093756325.SGD":"FTIF - Franklin K2 Alt Strat Fd A (acc) SGD-H1","SG9999001176.USD":"United Global Healthcare Acc USD","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","LU1430594728.SGD":"Eastspring Investments - Global Low Volatility Equity AS SGD","LU2236285917.USD":"ALLIANZ GLOBAL INCOME \"AMG\" (USD) INC","ARTY":"ISHARES FUTURE AI & TECH ETF","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","LU2362541513.USD":"WELLINGTON NEXT GENERATION GLOBAL EQUITY \"A\" (USD) ACC","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","LU1035775433.USD":"AB SICAV I - AMERICAN GROWTH PORTFOLIO \"AD\" (USD) INC","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","PBE":"INVESCO BIOTECHNOLOGY & GENOME ETF","LU0234570918.USD":"高盛全球核心股票组合Acc Close","LU0061475181.USD":"THREADNEEDLE (LUX) AMERICAN \"AU\" (USD) ACC","LU0432979614.USD":"JPM GLOBAL HEALTHCARE \"A\" ACC","LU1674673428.USD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AC\" (USD) ACC","IBB":"生物科技指数ETF-iShares Nasdaq","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","BBH":"VanEck Biotech ETF","GNMX":"Corgi Genomics & Precision Medicine ETF","LU2456880835.USD":"ALLIANZ GLOBAL INCOME \"AT\" (USD) ACC","LU0417517546.SGD":"Allianz US Equity Cl AT Acc SGD","VTHR":"Vanguard Russell 3000 ETF","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","BIB":"Ultra纳斯达克生物科","IE00B19Z9Z06.USD":"Legg Mason ClearBridge - US Aggressive Growth A Acc USD","BK4023":"应用软件","VRTX":"福泰制药","CHAT":"ROUNDHILL GENERATIVE AI & TECHNOLOGY ETF","AIPO":"Defiance AI and Power Infrastructure ETF","BK4532":"文艺复兴科技持仓","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC"},"translate_title":"摩根士丹利表示，由于人工智能担忧，顶点面临不确定的增长路径","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VERX":1.5,"VTHR":1.5,"CHAT":1.5,"TBXU":0.6,"AIPO":1.5,"IDNA":0.6,"IBB":0.6,"IBBQ":0.6,"ARTY":1.5,"GNMX":0.6,"AGIX":1.5,"BBH":0.6,"PBE":0.6,"BIB":0.6,"VRTX":1.5,"QTOC":1.5},"content_text":"Vertex (VERX) is going through a transition period, facing an uncertain path to growth as its end market remains reluctant to adopt artificial intelligence, Morgan Stanley said in a Tuesday note.With new Chief Executive Chris Young at the helm, the company is shaking up its leadership team and focusing on new product development, but it could still take time to improve net retention rate, the investment firm said.\"Given tax compliance requires high levels of accuracy, controls, and auditability, it will take time for these risk-averse buyers to get fully comfortable adopting and scaling new AI products,\" Morgan Stanley said, noting the AI opportunity in automating certain tax and compliance processes.The brokerage said the AI journey for Vertex could take relatively longer, but the company still has secular tailwinds such as e-invoicing and tax complexity.Morgan Stanley downgraded Vertex to equalweight from overweight and cut its price target to $15 from $19.Price: 12.15, Change: -0.74, Percent Change: -5.74","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.0","shortVersion":"4.47.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2653206786","isCrawlerRequest":true}